Revance Therapeutics
RVNC
HK$28.41
Share price
0.00%
Change (1 day)
-19.54%
Change (1 year)
Categories
Revance Therapeutics (RVNC) - Total assets
Total assets on the balance sheet as of September 2024 : HK$3.59 Billion
According to Revance Therapeutics's latest financial reports the company's total assets are HK$3.59 Billion. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Revance Therapeutics - Total assets on balance sheet (from 2012 to 2024)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | HK$3.73 B | -17.81% |
| 2022-12-31 | HK$4.54 B | 9.77% |
| 2021-12-31 | HK$4.14 B | -25.82% |
| 2020-12-31 | HK$5.58 B | 110.67% |
| 2019-12-31 | HK$2.65 B | 49.52% |
| 2018-12-31 | HK$1.77 B | -23.28% |
| 2017-12-31 | HK$2.31 B | 45.78% |
| 2016-12-31 | HK$1.58 B | -25.87% |
| 2015-12-31 | HK$2.13 B | 43.2% |
| 2014-12-31 | HK$1.49 B | 750.17% |
| 2013-12-31 | HK$0.17 B | 68.77% |
| 2012-12-31 | HK$0.10 B | -66.45% |
| 2011-12-31 | HK$0.31 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 | HK$0.43 B | -87.89% | 🇺🇸 USA |
 | HK$1.401 T | 38,920.37% | 🇺🇸 USA |
 | HK$218.29 B | 5,977.01% | 🇺🇸 USA |